Congratulations to the winners of the Christmas card contest!

For 4 years at Syva, we organize a drawing contest for the children and gran-children of our employees. The aim is to create postcards and reveal a little bit of the magic of Christmas through the eyes of the children.

There were 55 to participate. Traditionally, a winner is chosen in 3 age categories (3 to 5 years, 6 to 8 years and 9 to 12 years). Choosing the winners was not easy, as the participants were all very talented. All of them were rewarded, of course!

Our three winners – Victor, Pablo, and Daniela – were invited to Syva to receive their prizes. On this occasion, a small photo session was improvised, during which our director César Carnicer awarded them their prizes and a diploma for their artistic talents. Despite the Covid, the masks and the reduced audience, we did not want to spoil the pleasure of seeing their eyes shining with thousand stars!

You may also be interested in

13 May, 2024

The day after the first vaccinations in the Netherlands, Syva organised a round table in Utrecht focusing on the situation of bluetongue in this country and its BTV-3 vaccine.

Among those taking part in the day, many technical and practical questions that were answered by our experts, some of which reflected both the concern of being confronted once again with this BTV3 epidemic and a form of joy and relief at knowing that at the very moment many animals were being vaccinated.

Read more

10 May, 2024

The Belgian federal medicines agency, FAMHP, has now also authorised the use of the BTV3 vaccine developed by the Syva laboratories.

We are pleased to announce that, while Dutch veterinarians began mass vaccination on Monday 6 May, the Belgian veterinary health authorities on Wednesday 8 May authorised the use of Laboratories Syva's BTV3 vaccine under Article 110(2) of Regulation (EU) 2019/6.

Read more

26 April, 2024

Dutch authorities approved the use of the vaccine against bluetongue serotype 3 developed by Laboratorios Syva

After intensive work performed by our teams in our laboratories, an excellent coordination with the contract research organisations (CRO) which carried out the clinical trials necessary to test the vaccine's safety and efficacy, and an efficient communication with the authorities in the Netherlands, Syva Laboratories is pleased to announce that its vaccine against BTV 3 has been authorised for...

Read more